These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 899208)

  • 21. Physical characteristics of rubella virus.
    Smith KO; Hobbins TE
    J Immunol; 1969 Apr; 102(4):1016-23. PubMed ID: 4976665
    [No Abstract]   [Full Text] [Related]  

  • 22. An indirect immunocolorimetric assay to detect rubella virus infected cells.
    Chen MH; Zhu Z; Zhang Y; Favors S; Xu WB; Featherstone DA; Icenogle JP
    J Virol Methods; 2007 Dec; 146(1-2):414-8. PubMed ID: 17919742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic rubella virus-induced infection of human continuous cells].
    Andzhdaparidze OG; Desiatskova RG; Bogomolova NN; Cheliapov NV; Boriskin IuS
    Vopr Virusol; 1981; (5):586-92. PubMed ID: 6278775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Canadian Paediatric Society: recommended hospital practices relating to congenital rubella syndrome and rubella virus excretion].
    Can Med Assoc J; 1970 Apr; 102(7):750-4. PubMed ID: 5439334
    [No Abstract]   [Full Text] [Related]  

  • 25. THE IN VITRO GROWTH OF RUBELLA VIRUS IN HUMAN EMBRYO CELLS.
    PLOTKIN SA; BOUE A; BOUE JG
    Am J Epidemiol; 1965 Jan; 81():71-85. PubMed ID: 14246083
    [No Abstract]   [Full Text] [Related]  

  • 26. PERSISTENT INFECTION WITH RUBELLA VIRUS IN RK 13 CELLS.
    SVEDMYR A
    Arch Gesamte Virusforsch; 1965; 16():464-5. PubMed ID: 14322912
    [No Abstract]   [Full Text] [Related]  

  • 27. RUBELLA VIRUS: RECENT ADVANCES IN ITS ISOLATION.
    ALTMAN R
    Clin Pediatr (Phila); 1963 Aug; 2():433-8. PubMed ID: 14049450
    [No Abstract]   [Full Text] [Related]  

  • 28. RUBELLA. II. CLINICAL ASPECTS RELATED TO ISOLATION OF RUBELLA VIRUS.
    FORBES JA; BENNETT NM; GRAY NJ
    Med J Aust; 1963 Dec; 2():1016-9. PubMed ID: 14103619
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorescent plague assay of rubella virus infectivity.
    Hobbins TE; Smith KO
    Proc Soc Exp Biol Med; 1968 Nov; 129(2):407-12. PubMed ID: 4177060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of rubella virus on the human embryo].
    TONDURY G
    Helv Paediatr Acta; 1952 Apr; 7(2):105-36. PubMed ID: 14945771
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic infection of transplantable pig embryo kidney cells (PEK) by rubella virus].
    Andzhaparidze OG; Desiatkova RG; Cheliapov NV; Basova EA; Bogomolova NN
    Vestn Akad Med Nauk SSSR; 1977; (7):7-13. PubMed ID: 899208
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancement of rubella virus replication in swine testicle cells by co-infection with hog cholera virus.
    Soda K; Matumoto M
    Jpn J Microbiol; 1971 Sep; 15(5):397-406. PubMed ID: 5003257
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistent rubella virus infection in hamster lung cells.
    Downie JC; Oxford JS
    J Gen Virol; 1969 Jul; 5(1):11-7. PubMed ID: 4309921
    [No Abstract]   [Full Text] [Related]  

  • 34. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology of rubella. Subclinical infection and occurrence of reinfection.
    Horstmann DM; Pajot TG; Liebhaber H
    Am J Dis Child; 1969 Jul; 118(1):133-6. PubMed ID: 4978133
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.